Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Little Rock, Arkansas 72205


Purpose:

The purpose of this study is to learn how myeloma cells grow and become a cancer, how to distinguish them from normal cells and how to eliminate these cells selectively.


Study summary:

Participating in this study will require that blood and bone marrow samples be obtained as a part of the diagnostic work-up or follow-up of your multiple myeloma. Bone marrow/peripheral blood/tissue samples will be collected for research purposes, as well as testing for genetic traits of Castleman's disease if you consent to this study. In addition, data will be collected including demographic information gathered from your medical record, including gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology results, treatment protocols, dates of relapses, subsequent treatment protocols, and current treatments and medications.


Criteria:

Inclusion Criteria: - Any subject evaluated for a MIRT protocol Exclusion Criteria: - Subjects who have not been evaluated for a MIRT protocol


Study is Available At:


Original ID:

UARK 91-004


NCT ID:

NCT00572338


Secondary ID:


Study Acronym:


Brief Title:

Therapeutic Research in Multiple Myeloma


Official Title:

UARK 91-004 Therapeutic Research in Multiple Myeloma


Overall Status:

Completed


Study Phase:

N/A


Genders:

Both


Minimum Age:

18 Years


Maximum Age:

N/A


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

University of Arkansas


Oversight Authority:

United States: Institutional Review Board


Reasons Why Stopped:


Study Type:

Observational


Study Design:

Observational Model: Case-Only, Time Perspective:


Number of Arms:

0


Number of Groups:

1


Total Enrollment:

6388


Enrollment Type:

Actual


Overall Contact Information

Official Name:Bart Barlogie, MD, PhD
Principal Investigator
UAMS Myeloma Institute for Research and Therapy

Study Dates

Start Date:August 2003
Completion Date:March 2015
Completion Type:Actual
Primary Completion Date:March 2015
Primary Completion Type:Actual
Verification Date:August 2015
Last Changed Date:August 12, 2015
First Received Date:December 11, 2007

Study Outcomes

There are no available Study Outcomes

Study Interventions

Intervention Type:Other
Name:No drugs are involved
Description:No treatment or drugs are involved in this research. Participating in this study requires that blood and bone marrow samples be obtained as a part of the diagnostic work-up or follow-up of participant's multiple myeloma. Bone marrow/peripheral blood samples will be collected at the same time for research purposes. Data will be collected including demographic information gathered from your medical record, including gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology re
Arm Name:patients with myeloma/related diseases
Other Name:none, no treatment

Study Arms

Study Arm Type:Other
Arm Name:patients with myeloma/related diseases

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:University of Arkansas

Samples and Retentions

Sample Retention:Samples With DNA
Description: - A bone marrow aspirate and biopsy - Blood - Fine Needle aspirates - Swabs of skin, throat, other sites
Study Population: Samples will be studied in the laboratory and in experimental animal models. These analyses and animal models may help to better understand multiple myeloma and to better select the appropriate treatment for all participants with multiple myeloma.
Sample Method:Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.